These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17686225)

  • 1. Efavirenz-induced neurological symptoms in rare homozygote CYP2B6 *2/*2 (C64T).
    Usami O; Ashino Y; Komaki Y; Tomaki M; Irokawa T; Tamada T; Hayashida T; Teruya K; Hattori T
    Int J STD AIDS; 2007 Aug; 18(8):575-6. PubMed ID: 17686225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma efavirenz concentrations and the association with CYP2B6-516G >T polymorphism in HIV-infected Thai children.
    Puthanakit T; Tanpaiboon P; Aurpibul L; Cressey TR; Sirisanthana V
    Antivir Ther; 2009; 14(3):315-20. PubMed ID: 19474465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful efavirenz dose reduction in HIV type 1-infected individuals with cytochrome P450 2B6 *6 and *26.
    Gatanaga H; Hayashida T; Tsuchiya K; Yoshino M; Kuwahara T; Tsukada H; Fujimoto K; Sato I; Ueda M; Horiba M; Hamaguchi M; Yamamoto M; Takata N; Kimura A; Koike T; Gejyo F; Matsushita S; Shirasaka T; Kimura S; Oka S
    Clin Infect Dis; 2007 Nov; 45(9):1230-7. PubMed ID: 17918089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP2B6 G516T genotyping in a UK cohort of HIV-positive patients: polymorphism frequency and influence on efavirenz discontinuation.
    Powers V; Ward J; Gompels M
    HIV Med; 2009 Sep; 10(8):520-3. PubMed ID: 19486190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of rifampicin and CYP2B6 genotype on long-term efavirenz autoinduction and plasma exposure in HIV patients with or without tuberculosis.
    Ngaimisi E; Mugusi S; Minzi O; Sasi P; Riedel KD; Suda A; Ueda N; Janabi M; Mugusi F; Haefeli WE; Bertilsson L; Burhenne J; Aklillu E
    Clin Pharmacol Ther; 2011 Sep; 90(3):406-13. PubMed ID: 21814190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygous CYP2B6 *6 (Q172H and K262R) correlates with high plasma efavirenz concentrations in HIV-1 patients treated with standard efavirenz-containing regimens.
    Tsuchiya K; Gatanaga H; Tachikawa N; Teruya K; Kikuchi Y; Yoshino M; Kuwahara T; Shirasaka T; Kimura S; Oka S
    Biochem Biophys Res Commun; 2004 Jul; 319(4):1322-6. PubMed ID: 15194512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosis in a 12-year-old HIV-positive girl with an increased serum concentration of efavirenz.
    Lowenhaupt EA; Matson K; Qureishi B; Saitoh A; Pugatch D
    Clin Infect Dis; 2007 Nov; 45(10):e128-30. PubMed ID: 17968817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children.
    Saitoh A; Sarles E; Capparelli E; Aweeka F; Kovacs A; Burchett SK; Wiznia A; Nachman S; Fenton T; Spector SA
    AIDS; 2007 Oct; 21(16):2191-9. PubMed ID: 18090046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism.
    Burger D; van der Heiden I; la Porte C; van der Ende M; Groeneveld P; Richter C; Koopmans P; Kroon F; Sprenger H; Lindemans J; Schenk P; van Schaik R
    Br J Clin Pharmacol; 2006 Feb; 61(2):148-54. PubMed ID: 16433869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efavirenz pharmacokinetics in HIV-1-infected children are associated with CYP2B6-G516T polymorphism.
    Saitoh A; Fletcher CV; Brundage R; Alvero C; Fenton T; Hsia K; Spector SA
    J Acquir Immune Defic Syndr; 2007 Jul; 45(3):280-5. PubMed ID: 17356468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of CYP2B6-516G > T Polymorphism with Plasma Efavirenz Concentration and Depression in HIV-Infected Adults in Northern Thailand.
    Aurpibul L; Chotirosniramit N; Sugandhavesa P; Kosashunhanan N; Thetket S; Supindham T; Piyamongkol W; Supparatpinyo K
    Curr HIV Res; 2012 Dec; 10(8):653-60. PubMed ID: 22950382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of plasma efavirenz and CYP2B6 polymorphism in southern Chinese.
    To KW; Liu ST; Cheung SW; Chan DP; Chan RC; Lee SS
    Ther Drug Monit; 2009 Aug; 31(4):527-30. PubMed ID: 19531981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between ABCB1, CYP2A6, CYP2B6, CYP2D6, and CYP3A5 alleles in relation to efavirenz and nevirapine pharmacokinetics in HIV-infected individuals.
    Heil SG; van der Ende ME; Schenk PW; van der Heiden I; Lindemans J; Burger D; van Schaik RH
    Ther Drug Monit; 2012 Apr; 34(2):153-9. PubMed ID: 22354160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of host genetic factors on efavirenz plasma and intracellular pharmacokinetics in HIV-1-infected patients.
    Elens L; Vandercam B; Yombi JC; Lison D; Wallemacq P; Haufroid V
    Pharmacogenomics; 2010 Sep; 11(9):1223-34. PubMed ID: 20860463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study.
    Yimer G; Amogne W; Habtewold A; Makonnen E; Ueda N; Suda A; Worku A; Haefeli WE; Burhenne J; Aderaye G; Lindquist L; Aklillu E
    Pharmacogenomics J; 2012 Dec; 12(6):499-506. PubMed ID: 21862974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The convergence of therapeutic drug monitoring and pharmacogenetic testing to optimize efavirenz therapy.
    Cabrera Figueroa S; Fernández de Gatta M; Hernández García L; Domínguez-Gil Hurlé A; Bustos Bernal C; Sepúlveda Correa R; García Sánchez MJ
    Ther Drug Monit; 2010 Oct; 32(5):579-85. PubMed ID: 20720517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 2B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda.
    Penzak SR; Kabuye G; Mugyenyi P; Mbamanya F; Natarajan V; Alfaro RM; Kityo C; Formentini E; Masur H
    HIV Med; 2007 Mar; 8(2):86-91. PubMed ID: 17352764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver.
    Lang T; Klein K; Fischer J; Nüssler AK; Neuhaus P; Hofmann U; Eichelbaum M; Schwab M; Zanger UM
    Pharmacogenetics; 2001 Jul; 11(5):399-415. PubMed ID: 11470993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efavirenz intoxication due to slow hepatic metabolism.
    Hasse B; Günthard HF; Bleiber G; Krause M
    Clin Infect Dis; 2005 Feb; 40(3):e22-3. PubMed ID: 15668854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of high T allele frequency of CYP2B6 G516T polymorphism among ethnic south Indian HIV-infected patients with elevated plasma efavirenz and nevirapine.
    Ramachandran G; Ramesh K; Hemanth Kumar AK; Jagan I; Vasantha M; Padmapriyadarsini C; Narendran G; Rajasekaran S; Swaminathan S
    J Antimicrob Chemother; 2009 Apr; 63(4):841-3. PubMed ID: 19218571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.